Federal Circuit Confirms Validity Of Injectable Testosterone Patents
WASHINGTON, D.C. — A Delaware federal judge’s determination, following a bench trial, that two patents relating to the injectable testosterone drug Aveed are not invalid was not erroneous, the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article